ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 578

Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients

Ann-Sophie De Craemer1, Thomas Renson 1, Liselotte Deroo 1, Philippe Carron 1, Annelies Boonen 2, Xavier Janssens 3, Dirk Elewaut 1 and Filip Van den Bosch 1, 1Ghent University Hospital, Ghent, Belgium, 2Maastricht University Medical Center, Maastricht, Netherlands, 3AZ Sint-Lucas, Gent, Belgium

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: spondyloarthritis, Work Disability and Employment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Spondyloarthritis (SpA) generally affects patients at a working age. Despite therapeutic improvements, SpA remains responsible for a significant burden for patients and society in terms of sick leave and work disability. This study aims to assess the determinants of work participation in a Belgian SpA cohort.

Methods: Between May 1st 2018 and April 1st 2019, a cross-sectional survey was conducted amongst patients included in a Belgian SpA cohort ((Be-)Giant), all fulfilling ASAS classification criteria for axial or peripheral SpA. Information on work participation was collected using the Work Productivity and Activity Impairment (WPAI) questionnaire. Physicians’ assessment included standardized clinical and laboratory evaluations. Outcomes of interest were employment status (being employed yes/no), absenteeism (percentage of time absence from the workplace), presenteeism (percentage of productivity loss while at work) and percentage of overall work impairment. Continuous outcomes were categorized because of skewed (zero inflated) distributions. The associations between the four outcomes of interest and patient characteristics were modelled using univariate and multivariate logistic regression. The sample was restricted to SpA patients of working age (≤65 years old).

Results: Data were collected on 262 patients: 214 (81.7%) were employed, 26 (9.9%) work disabled, 8 (3.1%) unemployed, 8 (3.1%) student, 5 (1.9%) early retired and 1 (0.4%) housekeeper. Table 1 summarizes demographic and clinical characteristics. Table 2 shows univariate associations between patient characteristics and the outcomes of interest. Gender, age, symptom duration and SpA subtype are not significantly associated with any of the four outcomes. Higher education increases the odds of being employed and reduces the odds of absenteeism. Manual labour, high ASDAS-CRP and high BASFI show a negative association with employment and significantly increase the odds of absenteeism, presenteeism and overall work impairment. After multivariate adjustment, only ASDAS-CRP and BASFI showed a significant association with employment  status (OR 0.39 and 0.69), absenteeism (OR 2.54 and 1.71), presenteeism (OR 2.58 and 1.81) and work impairment (OR 2.67 and 1.82) (all p < 0,05).

Conclusion: High disease activity and functional impairment are significantly associated with work participation and overall work impairment in a Belgian SpA cohort. Of interest, neither gender, age, symptom duration, type of work nor SpA subtype significantly affect any of the work-related outcomes. Given the important health economic impact of employment rate in our society, this underscores the need for tight disease control in patients with SpA.

Table 1: Demographic and clinical characteristics

Table 2: Association between patient characteristics and work-related outcomes. -*p<0.05-


Disclosure: A. De Craemer, None; T. Renson, None; L. Deroo, None; P. Carron, None; A. Boonen, AbbVie, 2, Amgen, 2, Celgene, 2, Eli Lilly and Company, 5, Janssen, 8, Lilly, 5, 8, Novartis, 5, Sandoz, 5, 8, UCB, 5, 8; X. Janssens, None; D. Elewaut, None; F. Van den Bosch, AbbVie, 5, 8, Abbvie, 5, 8, AbbVie, Bristol-Myers Squibb, Celgene, Galapagos, Janssen, Lilly, MSD, Novartis, Pfizer, Sanofi and UCB, 5, 8, ABBVIE, CELGENE, ELI LILLY, GALAPAGOS, MERCK, NOVARTIS, PFIZER, VCB, 5, 8, Bristol-Myers Squibb, 2, 5, 8, Celgene, 5, 8, Eli Lilly, 5, 8, Galapagos, 5, 8, Janssen, 5, 8, Merck, 5, 8, Novartis, 5, 8, Pfizer, 5, 8, Sanofi, 5, 8, UCB, 5, 8.

To cite this abstract in AMA style:

De Craemer A, Renson T, Deroo L, Carron P, Boonen A, Janssens X, Elewaut D, Van den Bosch F. Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/restricted-work-participation-relates-to-high-disease-activity-in-spondyloarthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/restricted-work-participation-relates-to-high-disease-activity-in-spondyloarthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology